References►
A. Assisted Reproduction
A1.
Liu XR, Mu HQ, et al. The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis. Reprod Biol Endocrinol. 2012 Dec 13;10:107.
A2.
Hill MJ, Whitcomb BW, et al. Progesterone luteal support after ovulation induction and intrauterine insemination: a systematic review and meta-analysis. Fertil Steril. 2013 Nov;100(5):1373-1380.
A3.
van der Linden M, Buckingham K, et al. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev. 2015 Jul 7;(7):CD009154.
B. Miscarriage Prevention
B1.
Lim CE, Ho KK, et al. Combined oestrogen and progesterone for preventing miscarriage. Cochrane Database Syst Rev. 2013;(9):CD009278.
B2.
Coomarasamy A, Williams H, et al. A Randomized Trial of Progesterone in Women with Recurrent Miscarriages. N Engl J Med. 2015 Nov 26;373(22):2141-2148.
C. Pregnancy Support
C1.
Oler E, Eke AC, et al. Meta-analysis of randomized controlled trials comparing 17α-hydroxyprogesterone caproate and vaginal progesterone for the prevention of recurrent spontaneous preterm delivery. Int J Gynaecol Obstet. 2017;138(1):12-16.
C2.
Jarde A, Lustiv O, et al. Vaginal progesterone, oral progesterone, 17-OHPC, cerclage, and pessary for preventing preterm birth in at-risk singleton pregnancies: an updated systematic review and network meta-analysis. BJOG. 2019;126(5):556-567.
D. Premenstrual Syndrome
D1.
Ford O, Lethaby A, et al. Progesterone for premenstrual syndrome. Cochrane Database Syst Rev. 2012;(3):CD003415.
E. Traumatic Brain Injury
E1.
Ma J, Huang S, et al. Progesterone for acute traumatic brain injury. Cochrane Database Syst Rev. 2016;12:CD008409.
E2. Pan ZY, Zhao YH, et al. Effect of progesterone administration on the prognosis of patients with severe traumatic brain injury: a meta-analysis of randomized clinical trials. Drug Des Devel Ther. 2019;13:265-273.